African pharma are building an homegrown response to sickle cell disease
IMAGE: bird story agency Africa is beginning to build more of its own response to sickle cell disease, linking local research and clinical expertise with pharmaceutical manufacturing. As WHO pushes for wider access to hydroxyurea, […]
